Delftia Acidovorans Isolated from Pus Sample in Hospitalized Patient: First Case Report
Abstract
The Delftia acidovorans bacteria is an aerobic, Gram-negative, nonfermenting Bacillus bacterium. It is considered nonpathogenic bacterium for humans, commonly distributed through nature in water and plants and rarely it becomes pathogenic for human. For the first time a hospitalized man at age 70 who had been diagnosed with chronic emphysema by the physician was admitted to the microbiology lab for identification of the pathogen responsible for the emphysema. A pus specimen was cultured on the blood, MacConkey, and Chocolate agar by using the VITEK 2 system, which indicates that this bacterium is the main causative agent for emphysema. In this case report, Delftia acidovorans was isolated and found to be sensitive to some antibiotics, including Cefotaxime, Ceftazidim, Trimethoprim/sulfamethoxazole, Levofloxacin, Ciprofloxacin, Piperacillin/Tazobactam, Aztreonam, Imipenem, and Metropenem. This is the first case report of the isolation of Delftia acidovorans from pus in a hospitalized patient in Iraq, mainly in Duhok City. The isolation of D. acidovorans in the pus specimen from the hospitalized patient by culturing on the Blood agar, MacConkey agar, and Chocolate agar, indicates that this bacterium is the main causative agent for emphysema.
How strong is the evidence?
Evidence Hub reads this as a case report, done in people. Its evidence level is 5 of 5 (Very low · case / narrative / animal / in vitro / in silico). Case reports, narrative reviews, and animal, cell or computer-model studies give the weakest evidence for human health.
Read the paper
Related studies
- Ferulic acid regulates the AKT/GSK-3β/CRMP-2 signaling pathway in a middle cerebral artery occlusion animal model
- Novel Pharmacokinetic/Pharmacodynamic Parameters Quantify the Exposure–Effect Relationship of Levofloxacin against Fluoroquinolone-Resistant Escherichia coli
- Photochemical behavior of levofloxacin
- Correlation Between Dissolution Profiles of Salt-Form Drugs in Biorelevant Bicarbonate Buffer and Oral Drug Absorption: Importance of Dose/ Fluid Volume Ratio
- Evaluation of the synergistic potential and mechanisms of action for de novo designed cationic antimicrobial peptides
- Synthesis of [11C]levofloxacin
Go deeper in Evidence Hub
Evidence Hub adds a study data sheet (design, sample size, evidence level, key numbers), an AI summary and a chat grounded in the paper's text.